TDO has also been reported to be an immunosuppressive molecule capable of reducing CD8+ T cell viability, stimulating the secretion of cytokines such as IFN-γ, TNF-α, IL-10 and IL-17 by TDO reactive CD4+ T-cells, and contributes to the tumor metastasis (166–168). Here, CD8A is linked to neoplasm.